Blocking Carbohydrate Absorption and Weight Loss: A Clinical Trial Using Phase 2™ Brand Proprietary Fractionated White Bean Extract

Alternative Medicine Review

Volumn 9, Issue 1, 2004, Pages 63-69

  Udani, Jay ^a,b,c   Hardy, Mary ^d,e   Madsen, Damian C ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Northridge Hospital   (United States)

^c C Sinai Integrative Med Med Grp ^*  (United States)

^d C Sinai Integrative Med Med Grp   (Egypt)

^e USC School of Medicine   (United States)

^f California Neurosci Res Med Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CARBOHYDRATE; DEXFENFLURAMINE; FLUOXETINE; PHASE 2; PHASEOLAMIN 2250; PHASEOLUS VULGARIS EXTRACT; PLACEBO; PLANT EXTRACT; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CALORIC INTAKE; CARBOHYDRATE ABSORPTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INHIBITION; FECES INCONTINENCE; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; MALE; OBESITY; PHASEOLUS VULGARIS; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SEXUAL DYSFUNCTION; TENSION HEADACHE; TRIACYLGLYCEROL BLOOD LEVEL; VALVULAR HEART DISEASE; WEIGHT REDUCTION;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PHASEOLUS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 1642309790     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hansen B. Emerging strategies for weight management. Postgrad Med Special Report 2001;June:3-9.
2. Hensrud DD. Pharmacotherapy for obesity. Med Clin North Am 2000;84:463-476.
3. Layer P, Zinsmeister AR, Di Magno EP. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology 1986;91:41-48.
4. Layer P, Rizza RA, Zinsmeister AR, et al. Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus. Mayo Clin Proc 1986;61:442-447.
5. Bo-Linn GW, Santa Ana CA, Morawski SG, Fordtran JS. Starch-blockers - their effect on calorie absorption from a high-starch meal. N Engl J Med 1982;307:1413-1416.
6. Hollenbeck CB, Coulston AM, Quan R, et al. Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies. Am J Clin Nutr 1983;38:498-503.
7. Jensen N, Everone C, Rosenberg M. A study of the survival, body weights, health status, and food consumption of mice when given varying concentrations of raw bean meal and bean extract which contain Phaseolamin. Unpublished Data. 1982.
8. Maheshwari R, Srimal R, Kuttan R. Chronic toxicity studies of Phaseolamin 2250. Unpublished Data. 2002.
9. Meiss DE, Ballerini R. Effectiveness of Phase 2™, a natural alpha-amylase inhibitor, for weight loss: a randomized double-blind, placebo-controlled study. Presented at Scripps Clinic Natural Supplements in Evidence-Based Practice Conference. January 18, 2003.
10. Vinson J. Investigation on the efficacy of Phaseolamin 2250, a purified bean extract from Pharmachem Laboratories. Unpublished Data. University of Scranton. 2001.
11. Lewy VD, Danadian K, Arslanian S. Determination of body composition in African-American children: validation of bioelectrical impedance with dual energy X-ray absorptiometry. J Pediatr Endocrinol Metab 1999;12:443-448.
12. Meyer BH, Muller FO, Grigoleit HG, Clur BK. Inhibition of starch absorption by tendamistate (an alpha amylase inhibitor). S Afr Med J 1983;64:284-285.
13. Anonymous. Clinically studied Phaseolamin 2250 for non-stimulant carb control. http://www.phaseolamin2250.com/catalog7.htm. Accessed October 19, 2001.
14. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992;16:397-415.